dition of an A. aegypti extract. Mosquito-allergic individuals had significantly higher mean levels of rAed a 4-specific IgE and IgG than controls. Using the mean of the controls ± 2 SD as a cut-off level, 46% of the 13 allergic individuals had a positive IgE, while none of the controls was positive (p < 0.001). Conclusions: Aed a 4 is a major allergen in mosquito saliva. Its recombinant form has the hydrolase function and can be used for the diagnosis of mosquito allergy.
Introduction
Immunologic reactions to mosquito bites involve mosquito saliva-specific immunoglobulin E (IgE), IgG and cell-mediated hypersensitivity [1, 2] . The lack of readily available, specific, sensitive and safe tests for mosquito allergy is a major obstacle to accurate diagnosis.
Currently available mosquito whole-body extracts contain many extraneous proteins that are not present in mosquito saliva [3] . Immunoassays utilizing mosquito saliva as the allergen have significantly higher sensitivity and specificity for the diagnosis of mosquito allergy than those utilizing mosquito whole-body extract [4] ; however, collecting mosquito saliva is labor-intensive and im-practical [3] . Utilization of molecular techniques to clone and express pure mosquito salivary allergens thus has considerable diagnostic and therapeutic potential [5] .
The saliva of an adult female Aedes aegypti mosquito contains up to 55 proteins coded by salivary-gland-specific transcripts [6] . At least 10 of these proteins have been identified as allergens [7] . We previously cloned/expressed, purified, identified and evaluated 3 recombinant (r) A. aegypti mosquito salivary proteins in humans: rAed a 1 (68 kDa, apyrase) [8] , rAed a 2 (37 kDa, D7) [9] , and rAed a 3 (30 kDa, also called Aegyptin) [10] that are potentially useful in skin tests and the measurement of mosquito-specific IgE antibodies in serum.
Alpha-glucosidase from the adult salivary glands of A. aegypti is a 67-kDa, soluble glycoprotein that is secreted when mosquitoes take sugar and blood meals [11, 12] . In the present study, we expressed the α-glucosidase using a baculovirus/insect cell system, purified and characterized it and then explored its value in the in vitro diagnosis of mosquito allergy using an enzyme-linked immunosorbent assay (ELISA). In accordance with allergen nomenclature, this α-glucosidase was named Aed a 4. This nomenclature was accepted by the World Health Organization and International Union of Immunological Societies (WHO/IUIS) Allergen Nomenclature Subcommittee [13] .
Material and Methods

Serum Samples
Thirteen sera from individuals with a positive mosquito bite test from a laboratory-reared mosquito consisting of an immediate wheal or a delayed induration of ≥ 0.3 cm 2 and 18 sera from those with a negative mosquito bite test were obtained from our previous study [10] .
Construction of Recombinant Baculovirus Transfer Vector and Generation of Recombinant Baculovirus
The methods have been previously reported [10, 14] . Genomic and cDNA clones of the Aed a 4 gene (originally named maltaselike gene) were isolated and sequenced by James et al. [12] . Aed a 4 cDNA cloned as an EcoRI fragment into pEMBL plasmid [12] was provided by Dr. A.A. James, University of California, Irvine, Calif., USA. The 1.83-kb Aed a 4 cDNA fragment was digested from the cloned plasmid pEMBL by EcoRI and then cloned into the pVL1393 transfer vector. The baculoviruses containing Aed a 4 DNA for the expression of the recombinant protein (recombinant virus) were generated by cotransfection of Spodoptera frugiperda Sf9 cells with the recombinant transfer vector using the Bac-N-Blue transfection kit (version K). Plaque assays were performed and putative recombinant virus DNAs were prepared according to the manufacturer's instruction manual. Recombinant baculoviruses were identified by PCR using polyhedrin forward primer:
5 ′ -TTTACTGTTTTCGTAACAGTTTTG-3 ′ and reverse primer: 5 ′ -CAACAACGCACAGAAATCTAGC-3 ′ followed by PCR reactions. PCR products were analyzed and only pure recombinant viruses that contained the expected DNA fragment were selected as recombinant virus stock.
Expression and Purification
To increase the yield of expressed products, High Five cells (originated from the ovarian cells of the cabbage looper, Trichoplusia ni ) purchased from Invitrogen (San Diego, Calif., USA) grown in Express Five SFM serum-free medium were used [10, 14] . Purification of rAed a 4 from culture supernatants was performed by a combination of anion-and cation-exchange chromatography [14] . Proteins bound to a DEAE-Sephacel column were eluted with a linear NaCl gradient from 0 to 0.65 M in sodium phosphate buffer. Fractions were collected and assayed for protein concentration using the Bio-Rad protein assay and for rAed a 4 content using a hydrolase assay. Fractions containing rAed a 4 were pooled, dialyzed, centrifuged and loaded onto a CM-Sepharose column. Bound proteins were eluted with a linear NaCl gradient from 0 to 0.65 M . Fractions containing rAed a 4 were pooled, concentrated and subjected to SDS polyacrylamide gel electrophoresis (SDS-PAGE) for purity identification.
Hydrolase Assay
Aed a 4 is an α-glucosidase [11] . The activity of α-glucosidase was determined by the release of p-nitrophenolate from p-nitrophenyl-α-D-glucopyranoside (pNPG). Fifty microliters of 0.1 M sodium phosphate buffer (pH 7.0) containing 10 μ M pNPG, were added into each well of a 96-well, flat-bottomed microplate; 10 μl of test sample was added and mixed. About 20 min later, the plate was read at 410 nm.
Western Blot
To study whether rAed a 4 bound to the IgE in human mosquito-allergic serum, Western blot was performed using the materials and methods previously reported [10, 14] . Mosquito saliva was used as a positive control.
ELISA and ELISA Inhibition Test
ELISAs were developed to detect rAed a 4-specific IgE and IgG according to our previously reported Materials and Methods [14, 15] . In brief, microtiter plates, coated with 0.2 μg/well of purified rAed a 4 were incubated with human sera (diluted 1: 20 for IgE assay and 1: 200 for IgG assay). The bound serum rAed a 4-specific IgE was detected by serial incubations with goat IgG against human IgE, alkaline phosphatase-conjugated rabbit anti-goat IgG and an alkaline phosphatase substrate solution. The bound specific IgG was detected by incubations with monoclonal anti-human IgG, alkaline phosphatase-conjugated goat anti-mouse IgG, and the substrate solution.
An inhibition test was performed to examine whether the binding of human IgE to rAed a 4 could be inhibited by natural Aed a 4 in a mosquito extract and also to determine the specificity of the rAed a 4-specific IgE assay [10, 14] .
Statistical Analysis
Using GraphPad Prism software, unpaired Student's t tests were used for between-group comparisons and the χ 2 test was used to compare the positive percentages between groups.
Results
Construction and Generation of Recombinant Virus
Forty-four putative recombinant plaques were finally selected and viral DNAs were prepared. Three pure rAed a 4 virus plaques were confirmed by PCR analysis and used for the expression of rAed a 4 using High Five cells.
Purification rAed a 4, adsorbed by the DEAE-Sephacel matrix, was eluted at 0.3-0.4 M NaCl with other proteins ( fig. 1 a) . As the pooled fraction (fractions 25-30) was still contaminated with other proteins, CM-Sepharose chromatography was utilized for further purification. Almost all the contaminating proteins were excluded from the α-glucosidase functional peak that corresponded well with the protein peak ( fig. 1 b) . rAed a 4 was eluted at 0.3-0.4 M NaCl. Fractions 26-34 were pooled, concentrated to a final protein concentration of 2.5 mg/ml and subjected to SDS-PAGE. SDS-PAGE results indicated that the purified rAed a 4 showed one single 67-kDa band ( fig. 1 c) .
Identification
Both natural Aed a 4 in mosquito saliva and purified rAed a 4 bound to the IgE in pooled sera from mosquitoallergic individuals, confirming that these 2 forms have the same allergenicity ( fig. 1 d) .
In the ELISA inhibition test, the binding of serum Aed a 4-specific IgE to rAed a 4 was successfully inhibited by the addition of mosquito head and thorax extracts in a dose-dependent manner (data not shown), indicating that the rAed a 4 and the native Aed a 4 in these extracts have identical allergenicity and that the rAed a 4 capture-ELISA is specific for the detection of Aed a 4-specific IgE in human serum.
rAed a 4-Specific IgE and IgG
The mean levels of rAed a 4-specific IgE (p < 0.0079 and IgG (p < 0.004) were significantly higher in allergic individuals (n = 13) than in controls (n = 18) ( fig. 2 a) . Us- ing the mean of the controls ± 2 SD as a cut-off level, 46% of the 13 allergic individuals had a positive rAed a 4-specific IgE and none of the controls was positive (p < 0.001; fig. 2 b) . In the positivity of rAed a 4-specific IgG, there was no statistical significance between the 2 groups (p > 0.05).
Discussion
The purified rAed a 4 was shown to bind IgE in the sera of mosquito-allergic subjects, as measured by ELISA and immunoblot analysis. The binding of rAed a 4 to IgE could be inhibited by the addition of natural Aed a 4 present in the mosquito head and thorax extracts. The hydrolase assay indicated that rAed a 4 functions as a glucosidase. Taken together, these results indicate that rAed a 4 has identical allergenicity and biological activity to its natural form. Also, mean levels of rAed a 4-specific IgE and IgG were significantly higher in mosquito-allergic individuals than in controls.
Aed a 4 is an α-glucosidase that is secreted when mosquitoes ingest sugar or blood. As all mosquito species ingest sugar and blood, Aed a 4 might be possibly be a crossreactive allergen with other mosquito species; indeed, a similar α-glucosidase has been found in other mosquito species [16] . This is further supported by the results of this study, in which rAed a 4 bound to the IgE of mosquito-allergic individuals living in Manitoba where A. aegypti is not distributed [7] .
In this study, 46% of individuals with a positive mosquito-bite test had rAed a 4-specific IgE whereas only 29% have specific IgE to rAed a 1 [8] , 11% to rAed a 2 [17] and 46% to rAed a 3 [10] when the mean ± 2 SD of controls is used as a cut-off level. However, these studies were performed separately. A study to compare the results of serum-specific IgE for each allergen with a mosquito saliva-based ELISA simultaneously is in progress in our laboratory.
We did not perform skin tests with rAed a 4 in this study due to ethical limitations; however, we believe that rAed a 4 is capable of inducing skin reactions as it is also expressed by the baculovirus/insect cell system used to express rAed a 1, rAed a 2 and rAed a 3 and, in addition, has the function of α-glucosidase.
In summary, Aed a 4 is an important mosquito salivary allergen. In its recombinant form, it has biological functions and can be used for the confirmation of mosquito allergy. Serum rAed a 4-specific IgE and IgG levels and percentages in mosquito-bite test positive and negative individuals. a ELISA levels. Serum rAed a 4-specific IgE and IgG levels were measured using ELISA in 13 individuals with a positive bite test from a laboratory-reared mosquito. Eighteen individuals with a negative mosquito bite test served as controls. Values were expressed as mean ± SD. b Positivity. The geometric mean of the controls ± 2 SD was used as a cut-off level.
